105 related articles for article (PubMed ID: 11797802)
1. Long-term stability of West Nile virus IgM and IgG antibodies in diluted sera stored at 4 degrees C.
Wong SJ; Seligman SJ
Ann N Y Acad Sci; 2001 Dec; 951():369-72. PubMed ID: 11797802
[No Abstract] [Full Text] [Related]
2. Persistence of West Nile virus-specific antibodies in viremic blood donors.
Prince HE; Tobler LH; Yeh C; Gefter N; Custer B; Busch MP
Clin Vaccine Immunol; 2007 Sep; 14(9):1228-30. PubMed ID: 17652525
[TBL] [Abstract][Full Text] [Related]
3. West Nile virus epidemic, northeast Ohio, 2002.
Mandalakas AM; Kippes C; Sedransk J; Kile JR; Garg A; McLeod J; Berry RL; Marfin AA
Emerg Infect Dis; 2005 Nov; 11(11):1774-7. PubMed ID: 16318737
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a West Nile virus immunoglobulin A capture enzyme-linked immunosorbent assay.
Prince HE; Lapé-Nixon M
Clin Diagn Lab Immunol; 2005 Jan; 12(1):231-3. PubMed ID: 15643014
[TBL] [Abstract][Full Text] [Related]
5. A recombinant envelope protein-based enzyme-linked immunosorbent assay for West Nile virus serodiagnosis.
Wang T; Magnarelli LA; Anderson JF; Gould LH; Bushmich SL; Wong SJ; Fikrig E
Vector Borne Zoonotic Dis; 2002; 2(2):105-9. PubMed ID: 12653304
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of IgM and IgG antibodies to West Nile virus among blood donors in an affected area of north-eastern Italy, summer 2009.
Pezzotti P; Piovesan C; Barzon L; Cusinato R; Cattai M; Pacenti M; Piazza A; Franchin E; Pagni S; Bressan S; Martello T; Potenza R; Scipioni C; Ammendola R; Breda A; Palu G; Russo F; Rezza G
Euro Surveill; 2011 Mar; 16(10):. PubMed ID: 21435323
[TBL] [Abstract][Full Text] [Related]
7. West Nile virus infection in Ogbomoso: serological evidence.
Kolawole OE; Kola OJ
J Immunoassay Immunochem; 2015; 36(6):573-8. PubMed ID: 25714732
[TBL] [Abstract][Full Text] [Related]
8. Evaluations of commercial West Nile virus immunoglobulin G (IgG) and IgM enzyme immunoassays show the value of continuous validation.
Malan AK; Martins TB; Hill HR; Litwin CM
J Clin Microbiol; 2004 Feb; 42(2):727-33. PubMed ID: 14766844
[TBL] [Abstract][Full Text] [Related]
9. Immunoglobulin G avidity in differentiation between early and late antibody responses to West Nile virus.
Fox JL; Hazell SL; Tobler LH; Busch MP
Clin Vaccine Immunol; 2006 Jan; 13(1):33-6. PubMed ID: 16425997
[TBL] [Abstract][Full Text] [Related]
10. [Prevalence of antibodies to West Nile virus in youngsters from 5 to 20 years old in Madagascar].
Morvan J; Chin LH; Fontenille D; Rakotoarivony I; Coulanges P
Bull Soc Pathol Exot; 1991; 84(3):225-34. PubMed ID: 1764750
[TBL] [Abstract][Full Text] [Related]
11. Detection of intrathecal IgM, IgG and IgA in a Cuban West Nile virus confirmed case.
Pupo-Antúnez M; Dorta-Contreras AJ; Vazquez Y; González-Hernández M; Noris-García E; Padilla-Docal B; Bu-Coifiu-Fanego R
Arq Neuropsiquiatr; 2008 Sep; 66(3A):572-4. PubMed ID: 18813726
[No Abstract] [Full Text] [Related]
12. Use of immunoglobulin G avidity assays for differentiation of primary from previous infections with West Nile virus.
Levett PN; Sonnenberg K; Sidaway F; Shead S; Niedrig M; Steinhagen K; Horsman GB; Drebot MA
J Clin Microbiol; 2005 Dec; 43(12):5873-5. PubMed ID: 16333069
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic significance of immunoglobulin G avidity in symptomatic and asymptomatic West Nile virus infection.
Vilibic-Cavlek T; Kristofic B; Savic V; Kolaric B; Barbic L; Tabain I; Peric L; Sabadi D; Miklausic B; Potocnik-Hunjadi T; Zember S; Stevanovic V; Listes E; Savini G
Rev Soc Bras Med Trop; 2018; 51(5):591-595. PubMed ID: 30304263
[TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of West Nile virus in Iran.
Chinikar S; Shah-Hosseini N; Mostafavi E; Moradi M; Khakifirouz S; Jalali T; Goya MM; Shirzadi MR; Zainali M; Fooks AR
Vector Borne Zoonotic Dis; 2013 Aug; 13(8):586-9. PubMed ID: 23697768
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of West Nile Virus specific IgG and IgM antibodies in North-Western and Western provinces of Zambia.
Mweene-Ndumba I; Siziya S; Monze M; Mazaba ML; Masaninga F; Songolo P; Mwaba P; Babaniyi OA
Afr Health Sci; 2015 Sep; 15(3):803-9. PubMed ID: 26957968
[TBL] [Abstract][Full Text] [Related]
16. A study of West Nile virus infection in Iranian blood donors.
Sharifi Z; Mahmoodian Shooshtari M; Talebian A
Arch Iran Med; 2010 Jan; 13(1):1-4. PubMed ID: 20039761
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence of West Nile virus and tick-borne encephalitis virus in southeastern Turkey: first evidence for tick-borne encephalitis virus infections.
Ergunay K; Ozer N; Us D; Ozkul A; Simsek F; Kaynas S; Ustacelebi S
Vector Borne Zoonotic Dis; 2007; 7(2):157-61. PubMed ID: 17627432
[TBL] [Abstract][Full Text] [Related]
18. Comparison of ELISA and immunoassays for measurement of IgG and IgM antibody to West Nile virus in human sera against virus neutralisation.
Niedrig M; Sonnenberg K; Steinhagen K; Paweska JT
J Virol Methods; 2007 Jan; 139(1):103-5. PubMed ID: 17084464
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of West Nile virus antibodies in blood donors living in the metropolitan area of Milan, Italy, 2009-2011.
Gaibani P; Pierro A; Lunghi G; Farina C; Toschi V; Matinato C; Orlandi A; Zoccoli A; Almini D; Landini MP; Torresani E; Sambri V
New Microbiol; 2013 Jan; 36(1):81-3. PubMed ID: 23435819
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of IgG antibodies against West Nile virus in blood donors during the 2003 outbreak in Tunisia.
Riabi S; Gallian P; Gaaloul I; Simon S; Harrath R; Hassine M; de Micco P; Aouni M
Trans R Soc Trop Med Hyg; 2010 Jul; 104(7):507-9. PubMed ID: 20356614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
